<DOC>
	<DOC>NCT00900029</DOC>
	<brief_summary>The objective of this study is to examine the durability of previous target wound closures, identify new test article-related adverse events, record new target wound closures, and examine ongoing adverse events not resolved in subjects who participated in HP 802-247-09-015.</brief_summary>
	<brief_title>Safety Follow-Up to HP 802-247-09-015</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<mesh_term>Postphlebitic Syndrome</mesh_term>
	<mesh_term>Postthrombotic Syndrome</mesh_term>
	<criteria>INCLUSION CRITERIA: Provide informed consent Willing to comply with protocol instructions, including allowing all study assessments. Subject was randomized in HP 80224709015 and received at least one application of a test article, whether active or placebo. Subject has ended their participation in HP 80224709015 by virtue of completing the study, or by dropping out prior to completion. Exclusion Criteria Subjects who refuse to provide written informed consent will be excluded from this trial.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Venous Leg Ulcer</keyword>
	<keyword>Venous Stasis Ulcer</keyword>
	<keyword>VLU</keyword>
	<keyword>VSU</keyword>
	<keyword>Leg Ulcer</keyword>
	<keyword>Leg Wound</keyword>
</DOC>